Clovis Oncology
CLVS
#9778
Rank
โ‚ฌ11.23 M
Marketcap
0,07754ย โ‚ฌ
Share price
0.00%
Change (1 day)
-94.87%
Change (1 year)

Clovis Oncology (CLVS) - P/B ratio

P/B ratio as of November 2024 : -0.0282

According to Clovis Oncology's latest financial reports the company has a price-to-book ratio of 0.0884849.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Clovis Oncology - P/B ratio (from 2011 to 2022)

P/B ratio by year

Year P/B ratio Change
2022-12-31-0.0282-97.76%
2021-12-31-1.25-59.98%
2020-12-31-3.14-4.63%
2019-12-31-3.29-150.78%
2018-12-316.47-30.49%
2017-12-319.31-101.97%
2016-12-31-472-10661.86%
2015-12-314.47-22.17%
2014-12-315.7439.83%
2013-12-314.1030.64%
2012-12-313.1435.62%
2011-12-312.32
2010-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.23-8,030.76%๐Ÿ‡บ๐Ÿ‡ธ USA
5.03-17,964.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
1.54-5,562.61%๐Ÿ‡บ๐Ÿ‡ธ USA
5.34-19,045.66%๐Ÿ‡บ๐Ÿ‡ธ USA
50.0-177,570.32%๐Ÿ‡บ๐Ÿ‡ธ USA
49.7-176,593.98%๐Ÿ‡บ๐Ÿ‡ธ USA